Equifax has issued new fixed-rate notes across senior, subordinated, and unsecured tranches, a move that affects both bondholders and equity investors. The stock has been volatile, with a one-month return of 12.39% but a year-to-date decline of 19.17% and a one-year total shareholder return down 26.67%. Equifax now trades about 26% below the average analyst target and carries an estimated 52% intrinsic discount based on a discounted cash flow model, which pegs fair value at $362.86 versus the current price of $173. On a price-to-earnings basis, the stock trades at 29.8 times, above the estimated fair P/E of 28.1 times, the peer average of 26.9 times, and the US Professional Services industry average of 21.8 times, indicating a premium valuation that could narrow if sentiment shifts or revenue growth slows.
Equifax IncEquifax issued new debt and trades at a discount to DCF fair value, but the impact is mixed: debt issuance can dilute equity or signal financial maneuvering, while the DCF discount suggests undervaluation.